| Witnesses |
| Panel: |
| | The Honorable Donna M. Christian-Christensen, M.D., a Delegate to Congress from the United States Virgin Islands |
|
| Panel: |
| | Leslie V. Norwalk, Acting Administrator, Centers for Medicare and Medicaid Services |
| | Robert A. Vito, Regional Inspector General for the Office of Evaluation and Inspections, U.S. Department of Health and Human Services, Philadelphia, Pennsylvania |
| | John K. Jenkins, M.D., Director, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland |
|
| Panel: |
| | Ajay K. Singh, M.D., Clinical Director, Renal Division, Director, Dialysis Services, Associate Professor of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts |
| | Kris Robinson, Executive Director and CEO, American Association of Kidney Patients, Tampa, Florida |
| | Alan S. Kliger, M.D., President, Renal Physicians Association, Rockville, Maryland |